Bahija Jallal
Director · Elevance Health, Inc.
- 2025
- May 15, 2026
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Bahija Jallal files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- David M. Berman - $3.92M in IMCR purchases and sales in the last 12 months
- Gail Boudreaux - $1.00M in ELV purchases and sales in the last 12 months
- Charles Morgan Kendrick Jr. - $911K in ELV purchases and sales in the last 12 months
- Steven H. Collis - $870K in ELV purchases and sales in the last 12 months
- Ronald W. Penczek - $766K in ELV purchases and sales in the last 12 months
- Ramiro G. Peru - $366K in ELV purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Bahija Jallal?
Bahija Jallal is a corporate insider, tracked as Director of Elevance Health, Inc. (ELV). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Bahija Jallal last file a Form 4?
The most recent primary Form 4 on record is dated 15 May 2026, one of 3 filings going back to 2025.
Has Bahija Jallal been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($371K) across all tracked filings.
